SEC Form 4 · accession 0001179110-15-011685
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard John Roberts
Director
Period of report
Jul 31, 2015
Accepted (ET)
Aug 4, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001292519
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | $14.55 | Jul 31, 2015 | A | 12,500 | A | Jul 31, 2015 | Jul 31, 2025 | COMMON STOCK | 12,500 | 12,500 | D |